A Global Registry on Second GEneration and Long-acting InTegrase InhibiTor FAilures

Enrolling by invitationOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

September 1, 2024

Study Completion Date

September 1, 2025

Conditions
HIVTherapy Failure
Trial Locations (1)

Unknown

University Medical Center Utrecht, Utrecht

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Luxembourg Institute of Health

OTHER_GOV

collaborator

Erasmus Medical Center

OTHER

lead

UMC Utrecht

OTHER

NCT06706986 - A Global Registry on Second GEneration and Long-acting InTegrase InhibiTor FAilures | Biotech Hunter | Biotech Hunter